Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seiki Wada

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Clinical Calcium|October 3, 2008
[Newly developed drugs for osteoporosis in overseas and their future roles for the therapy]Seiki Wada, Takeshi Fukawa, Sadahiro Kamiya
Clinical Calcium|November 6, 2007
[Osteocalcin and bone]Seiki Wada, Takeshi Fukawa, Sadahiro Kamiya
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 18, 2003
[Glucocorticoid-induced osteoporosis]Shigemitsu Yasuda, Masakazu Kogawa, Seiki Wada
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 28, 2007
[New bone density conservation agents for osteoporosis under research and development: Zoledronate]Seiki Wada, Takeshi Fukawa, Sadahiro Kamiya
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 24, 2004
[Osteoporosis in patients with hyperthyroidism]Shinji Kitahama, Toshiaki Ishii, Seiki Wada
Clinical Calcium|April 2, 2005
[Treatment with bisphosphonates: daily or once-weekly oral administration and intravenous injection]Shinji Kitahama, Toshiaki Ishii, Seiki Wada
Clinical Calcium|December 7, 2007
[Parathyroid and bone. Evidence and perspective of parathyroid therapy for patients with osteoporosis]Seiki Wada, Takeshi Fukawa, Sadahiro Kamiya
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 11, 2005
[Physiological actions of calcitonin gene-related peptide]Seiki Wada, Sadahiro Kamiya, Katsuhiro Ono
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 28, 2007
[New bone density conservation agents for osteoporosis under research and development: Anti-RANKL antibody]Seiki Wada, Takeshi Fukawa, Sadahiro Kamiya
Clinical Calcium|May 7, 2005
[Bisphosphonates: the molecular targets and mechanisms of action]Seiki Wada, Sadahiro Kamiya, Katsuhiro Ono
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Clinical Calcium|October 3, 2008
[Newly developed drugs for osteoporosis in overseas and their future roles for the therapy]Seiki Wada, Takeshi Fukawa, Sadahiro Kamiya
Clinical Calcium|November 6, 2007
[Osteocalcin and bone]Seiki Wada, Takeshi Fukawa, Sadahiro Kamiya
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 18, 2003
[Glucocorticoid-induced osteoporosis]Shigemitsu Yasuda, Masakazu Kogawa, Seiki Wada
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 28, 2007
[New bone density conservation agents for osteoporosis under research and development: Zoledronate]Seiki Wada, Takeshi Fukawa, Sadahiro Kamiya
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 24, 2004
[Osteoporosis in patients with hyperthyroidism]Shinji Kitahama, Toshiaki Ishii, Seiki Wada
Clinical Calcium|April 2, 2005
[Treatment with bisphosphonates: daily or once-weekly oral administration and intravenous injection]Shinji Kitahama, Toshiaki Ishii, Seiki Wada
Clinical Calcium|December 7, 2007
[Parathyroid and bone. Evidence and perspective of parathyroid therapy for patients with osteoporosis]Seiki Wada, Takeshi Fukawa, Sadahiro Kamiya
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 11, 2005
[Physiological actions of calcitonin gene-related peptide]Seiki Wada, Sadahiro Kamiya, Katsuhiro Ono
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 28, 2007
[New bone density conservation agents for osteoporosis under research and development: Anti-RANKL antibody]Seiki Wada, Takeshi Fukawa, Sadahiro Kamiya
Clinical Calcium|May 7, 2005
[Bisphosphonates: the molecular targets and mechanisms of action]Seiki Wada, Sadahiro Kamiya, Katsuhiro Ono
Pageof 4